Remember you found this company at Infoisinfo
905-362-297?
Viventia is developing and advancing the next generation of human antibody-based therapeutics for use in oncology. This differential targeting enhances the therapeutic potential of our drugs and provides prolonged clinical benefit. Viventia has developed a potent payload, deBouganin, that when coupled to a targeting antibody can effectively kill cancer cells without harming normal cells. Our approach combines the specificity of an antibody with the potency of a cytotoxic payload to provide targeted therapies for the safer and more efficacious treatment of cancer patients. The versatile deBouganin payload has been chemically conjugated to full length antibodies as well as fused to numerous antibody fragments and has been found to be safe and efficacious in the clinic.
We don't have any social media account of this company
This business has no pictures or videos
Do you own a business?
We help you grow it
Get more clients, visibility and branding.
Let us help you achieve your targets and improve your business.
Reviews of Viventia Biotech Inc (0)